Pluristyx Inc., the leader in advanced induced pluripotent stem cell (iPSC) technologies, announces today the Initial Close of their Series A financing led by a global Fortune 500 company along with ...

Biomedical engineers use iPSCs to grow specialized retinal endothelial cells, successfully regenerating damaged eye blood ...

Ancient genes from single-celled organisms have been used to reprogram mouse cells and influence embryonic development, ...

Aging, at its most fundamental level, is a molecular process. Chemical marks on the genome shift and lose fidelity over time, ...

Sparkling Sciences Co., Ltd., under TOMO YUME Group, announced it has obtained international INCI certification for iPSC Exosome and completed Kyoto University's patent licensing agreement. INCI Name: ...

In oncology, the manipulation of metabolic processes within tumors has surfaced as a pivotal strategy for influencing cancer progression and therapy resistance. Tumor cells often undergo metabolic ...

Proprietary Synthetic Polynucleotide Platform Accelerates Non-Viral, Footprint-Free Induced Pluripotent Stem Cell Generation Amid Surging Commercialization of iPSC Therapies in JapanSEATTLE, June 16, ...

Andy Lupini, distinguished R&D staff member of ORNL’s Electron Microscopy and Microanalysis Group, and Kevin Roccapriore — on entrepreneurial leave from ORNL’s Data NanoAnalytics Group to launch the ...

Abstract: Accurate and timely air quality prediction is crucial for cities and individuals to effectively take necessary precautions against potential air pollution. Existing studies typically rely on ...

A novel combination of mRNA technology and immune modulation may offer a new strategy for treating allergic diseases, according to new research demonstrating enhanced immune tolerance and reduced ...

Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before. Earlier this week, Life Biosciences, a biotech company focused on reversing age-related ...